SCHEMBL4865208

SCHEMBL4865208

Nc1cccc(C(=O)O)c1C(=O)c1ccccc1C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS2R14 Q9NYV8 2/20 0.46
UCHL1 P09936 1/20 0.46
GAA P10253 2/20 0.45
LMNA P02545 1/20 0.45
MMP2 P08253 1/20 0.45
PTGS1 P23219 1/20 0.45
FABP4 P15090 1/20 0.45
HSD17B10 Q99714 2/20 0.44
HTT P42858 1/20 0.44
CNR2 P34972 2/20 0.43
RORB Q92753 1/20 0.42
ALDH1A1 P00352 2/20 0.42
KCNK3 O14649 1/20 0.42
KCNK9 Q9NPC2 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CDK2 P24941 1/20 0.41
MAPT P10636 1/20 0.41
KDM4E B2RXH2 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4849042 0.85 MMP2 (0.45) TAS2R14GAALMNAMMP2HSD17B10
SCHEMBL4865222 0.81 UCHL1 (0.50) TAS2R14UCHL1GAALMNAPTGS1
SCHEMBL8989958 0.80 GAA (0.53) UCHL1GAALMNAPTGS1HSD17B10
SCHEMBL20641903 0.79 CNR2 (0.55) TAS2R14UCHL1GAALMNAPTGS1
SCHEMBL6917724 0.79 MAPT (0.66) GAAMMP2HSD17B10HTTALDH1A1
SCHEMBL283130 0.79 HSD17B10 (0.41) TAS2R14GAALMNAMMP2PTGS1
SCHEMBL4870178 0.78 CDK2 (0.44) GAAMMP2HSD17B10HTTKCNK3
SCHEMBL221518 0.78 LMNA (0.62) TAS2R14GAALMNAFABP4CNR2
SCHEMBL30449216 0.78 LMNA (0.62) TAS2R14GAALMNAFABP4CNR2
SCHEMBL11857703 0.78 RECQL (0.48) GAALMNAPTGS1RORBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293790-A1 SUBSTITUTED ARYL OXIMES WYETH (US) 2008-11-27 US disclosed
US-7420083-B2 Substituted aryloximes WYETH (US) 2008-09-02 US disclosed
US-20050070584-A1 Substituted aryloximes WYETH (US) 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070584-A1 Substituted aryloximes AHR, NQO1, AOX1 TAS2R14 4553/4885UCHL1 1969/4885GAA 2649/4885
US-20080293790-A1 SUBSTITUTED ARYL OXIMES HCCS, AOX1, TET2 TAS2R14 3694/4885UCHL1 1379/4885GAA 2012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.